These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Overcoming the challenges in the pharma/biotech industry. Graul AI; Prous JR Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900 [TBL] [Abstract][Full Text] [Related]
23. Pharmacogenetics and drug metabolism. Ball S; Borman N Nat Biotechnol; 1997 Oct; 15(10):925-6. PubMed ID: 9335033 [No Abstract] [Full Text] [Related]
24. Transforming the work of early-stage drug discovery through bioprocess informatics. Holzman TF; Hebert EJ Drug Discov Today; 2005 Jan; 10(1):61-7. PubMed ID: 15676300 [TBL] [Abstract][Full Text] [Related]
25. The evolving role of collaboration in biotechnology. Gower JM Nat Biotechnol; 1998 May; 16 Suppl():31-2. PubMed ID: 9591261 [No Abstract] [Full Text] [Related]
26. Trends in disease focus of drug development. Karlberg JP Nat Rev Drug Discov; 2008 Aug; 7(8):639-40. PubMed ID: 18670429 [No Abstract] [Full Text] [Related]
27. Optimizing the impact of genomics on drug discovery and development. Crooke ST Nat Biotechnol; 1998 May; 16 Suppl():29-30. PubMed ID: 9591260 [No Abstract] [Full Text] [Related]
28. Study critiques corporate control of trials. Niiler E Nat Biotechnol; 2002 Dec; 20(12):1180. PubMed ID: 12454659 [No Abstract] [Full Text] [Related]
29. The time is now. Nat Rev Drug Discov; 2005 Aug; 4(8):613. PubMed ID: 16106580 [No Abstract] [Full Text] [Related]
30. The hunt for a new drug: five views from the inside. Mervis J Science; 2005 Jul; 309(5735):722. PubMed ID: 16051781 [No Abstract] [Full Text] [Related]
31. Antibacterial drug discovery: is small pharma the solution? Boggs AF; Miller GH Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038 [TBL] [Abstract][Full Text] [Related]
33. Into the 21st century. Biotechnology and the pharmaceutical industry in the next ten years. Drews J Biotechnology (N Y); 1993 Mar; 11(3):S16-20. PubMed ID: 7763432 [No Abstract] [Full Text] [Related]
34. New pharma-biotech company formation in India. Saberwal G Nat Biotechnol; 2006 May; 24(5):499-501. PubMed ID: 16680124 [No Abstract] [Full Text] [Related]
35. An audience with James Greenwood. Greenwood J Nat Rev Drug Discov; 2008 Jun; 7(6):470. PubMed ID: 18511925 [No Abstract] [Full Text] [Related]
36. Trends in the development of chiral drugs. Caner H; Groner E; Levy L; Agranat I Drug Discov Today; 2004 Feb; 9(3):105-10. PubMed ID: 15038394 [No Abstract] [Full Text] [Related]
38. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening]. Schirlin D; Galvan M; Le Fur G Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426 [TBL] [Abstract][Full Text] [Related]
39. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry. Rubin AE; Tummala S; Both DA; Wang C; Delaney EJ Chem Rev; 2006 Jul; 106(7):2794-810. PubMed ID: 16836299 [No Abstract] [Full Text] [Related]
40. Trends in antimicrobial drug development: implications for the future. Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]